IL-28B predicts response to chronic hepatitis C therapy--fine-mapping and replication study in Asian populations.
IL-28B predicts response to chronic hepatitis C therapy--fine-mapping and replication study in Asian populations. J Gen Virol. 2011 May; 92(Pt 5):1071-1081.